Model
Edge
RVL Pharmaceuticals
0001753129
Filing Type
4
Filing Date
10/19/2023
Updated
10/20/23, 7:36 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership